Bio Farma

DENSO, Global Mobility Service to Support Delivery of COVID-19 Test Kits in Indonesia

Monday, May 18, 2020 - 9:36am

Health care workers in Indonesia have relied on imported PCR test kits to trace and fight the virus, but growing demand has caused a shortage of these critical tests.

Key Points: 
  • Health care workers in Indonesia have relied on imported PCR test kits to trace and fight the virus, but growing demand has caused a shortage of these critical tests.
  • was launched to mass-produce 100 thousand PCR testing kits in Indonesia.
  • In this project, Bio Farma, an Indonesian state-run pharmaceutical company, has already started mass production of PCR test kits.
  • (2) Mobility Service Platform is a platform system that performs management, control, data analysis, etc.

Batavia Biosciences receives $6.5M grant to take next step towards polio-free world

Monday, September 16, 2019 - 12:00pm

Chris Yallop, CSO of Batavia Biosciences, explains: The nOPV2 vaccine, provided by our partner Bio Farma, is currently the most advanced in clinical development and most in demand.

Key Points: 
  • Chris Yallop, CSO of Batavia Biosciences, explains: The nOPV2 vaccine, provided by our partner Bio Farma, is currently the most advanced in clinical development and most in demand.
  • The platform combines Univercells NevoLine manufacturing technology with Batavia Biosciences Highly Intensified Process ( HIP -Vax) technology for viral vaccines.
  • Menzo Havenga, CEO of Batavia Biosciences, comments: We are very excited to work with these eminent partners and take the next step towards a polio-free world.
  • Headquartered in Leiden, the Netherlands, with a subsidiary in Woburn, Massachusetts, and offices in Hong Kong, Batavia Biosciences is privileged to have strong strategic partners worldwide.

Indonesia's Medicine Regulator Holds the First Meeting of the Heads of NMRAs of OIC Countries Towards Medicines and Vaccines Self Reliance

Friday, November 23, 2018 - 6:59am

The diverse condition of political and economies in OIC member states made several limitation of access towards medicine and vaccines in some of OIC member states.

Key Points: 
  • The diverse condition of political and economies in OIC member states made several limitation of access towards medicine and vaccines in some of OIC member states.
  • Moreover, infectious diseases are still a big problem for a number of the OIC member states.
  • Indonesia through Bio Farma has exported vaccines to 141 countries, including 49 OIC member states.
  • In terms of vaccines production capabilities, Indonesia is one of leading countries among member of OIC.